BVS - Bioventus - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BVS is currently covered by 3 analysts with an average price target of $15.6. This is a potential upside of $4.4 (19.45%) from yesterday's end of day stock price of $13.06.

Bioventus's activity chart (see below) currently has 23 price targets and 30 ratings on display. The stock rating distribution of BVS is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 48.98% with an average time for these price targets to be met of 185.07 days.

Highest price target for BVS is $19, Lowest price target is $14, average price target is $15.6.

Most recent stock forecast was given by CAITLIN CRONIN from CANACCORD on 17-Aug-2026. First documented stock forecast 08-Mar-2021.

Currently out of the existing stock ratings of BVS, 7 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 01-Oct-2024

$19

$4.93 (35.04%)

$15

25 days ago
(17-Aug-2026)

6/7 (85.71%)

$5.12 (36.89%)

379

Buy Since 09-Feb-2026

$14

$-0.07 (-0.50%)

$14

2 months 12 days ago
(30-Jun-2026)

4/4 (100%)

$4.56 (48.31%)

108

Buy Since 13-Mar-2024

$16

$6.22 (63.60%)

$15

6 months 5 days ago
(06-Mar-2026)

2/6 (33.33%)

$7.59 (90.25%)

205

Buy Since 07-Jul-2025

$14

$-0.07 (-0.50%)

$12

1 years 1 months ago
(11-Aug-2025)

2/2 (100%)

$7.07 (102.02%)

363

Sell Since 17-Dec-2024

$13

$-1.07 (-7.60%)

1 years 8 months 25 days ago
(17-Dec-2024)

1/1 (100%)

$1.85 (16.59%)

588

Show more analysts

Please expand the browser size to see the chart

What is BVS (Bioventus) average time for price targets to be met?

On average it took 185 days for the stock forecasts to be reached, with an average price target met ratio of 48.98%.

Which analyst most recently updated their price target on BVS (Bioventus)?

Caitlin Cronin

Which analyst has the most public recommendations on BVS (Bioventus)?

Caitlin Cronin works at CANACCORD and has 12 price targets and 6 ratings on BVS

Which analyst is the currently most bullish on BVS (Bioventus)?

Drew Ranieri with the highest potential upside of $8.81

Which analyst is the currently most reserved on BVS (Bioventus)?

Amit Hazan with the lowest potential downside of -$6.56

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?